| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 5'-香叶基-5,7,2',4'-四羟基黄酮; 5'-Geranyl-5,7,2',4'-tetrahydroxyflavone | CFN92321 | 1221762-70-4 | C25H26O6 = 422.5 | 5mg | QQ客服：3257982914 |
| 3-香叶基-5,7,2',4'-四羟基黄酮; 5,7,2',4'-Tetrahydroxy-3-geranylflavone | CFN92322 | 376361-87-4 | C25H26O6 = 422.5 | 5mg | QQ客服：215959384 |
| Albanin A; Albanin A | CFN92325 | 73343-42-7 | C20H18O6 = 354.4 | 5mg | QQ客服：215959384 |
| beta-鼠李素; beta-Rhamnocitrin | CFN92328 | 90-19-7 | C16H12O7 = 316.3 | 5mg | QQ客服：3257982914 |
| 苦参醇W; Kushenol W | CFN92342 | 254886-76-5 | C21H22O7 = 386.4 | 5mg | QQ客服：1413575084 |
| 勒奇黄烷酮G; Leachianone G | CFN92343 | 152464-78-3 | C20H20O6 = 356.4 | 5mg | QQ客服：1457312923 |
| 苦参醇L; Kushenol L | CFN92344 | 101236-50-4 | C25H28O7 = 440.5 | 5mg | QQ客服：1457312923 |
| 苦参醇M; Kushenol M | CFN92345 | 101236-51-5 | C30H36O7 = 508.6 | 5mg | QQ客服：215959384 |
| 8-异戊烯基山柰酚; 8-Prenylkaempferol | CFN92346 | 28610-31-3 | C20H18O6 = 354.4 | 5mg | QQ客服：3257982914 |
| Afrormosine; Afrormosine | CFN92347 | 550-79-8 | C17H14O5 = 298.3 | 5mg | QQ客服：1413575084 |
| 苦参醇B; Kushenol B | CFN92348 | 99217-64-8 | C30H36O6 = 492.6 | 5mg | QQ客服：2159513211 |
| 白杨素 6-C-葡萄糖苷; Chrysin 6-C-glucoside | CFN92360 | 28368-57-2 | C21H20O9 = 416.4 | 5mg | QQ客服：2056216494 |
| 黄芩素 6-O-葡萄糖苷; Baicalein 6-O-glucoside | CFN92361 | 28279-72-3 | C21H20O10 = 432.4 | 5mg | QQ客服：1457312923 |
| 香风草甙; Didymin | CFN92363 | 14259-47-3 | C28H34O14 = 594.6 | 20mg | QQ客服：215959384 |
| 5,7-二羟基色原酮 7-芸香糖苷; 5,7-Dihydroxychromone 7-rutinoside | CFN92369 | 52538-46-2 | C21H26O13 = 486.4 | 5mg | QQ客服：1457312923 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)